Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922894 · ClinicalTrials.gov registry record · Phase 4
Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury
A Phase 4 study of Spinal Cord Injury and Sleep Apnea, sponsored by John D. Dingell VA Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02922894 is a Phase 4 study of Spinal Cord Injury and Sleep Apnea that is actively recruiting participants, run by John D. Dingell VA Medical Center. The registered enrollment target is 100 participants, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02922894, a Phase 4 study of Spinal Cord Injury and Sleep Apnea, is actively recruiting participants, sponsored by John D. Dingell VA Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate potential therapeutic approaches for sleep-disordered breathing (SDB) in patients with chronic cervical spine injury (\>6 months post-injury).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Trazodone
- PROCEDURE Acute episodic hypoxia
- PROCEDURE Supplemental oxygen
- PROCEDURE Sham
Study Locations (1)
Michigan
- John D. Dingell VA Medical Center - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-06-09 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02922894
The ClinicalTrials.gov registry entry for NCT02922894 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (18% higher). The listed sponsor is John D. Dingell VA Medical Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT02922894 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT02922894 about?
NCT02922894 is a clinical study titled "Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury". This study will investigate potential therapeutic approaches for sleep-disordered breathing (SDB) in patients with chronic cervical spine injury (\>6 months post-injury).
What is the current status of trial NCT02922894?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2017-06-09. Estimated completion is 2026-06-30.
What conditions does trial NCT02922894 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Sleep Apnea.
What interventions are being tested in trial NCT02922894?
The interventions under investigation include: Placebo (DRUG), Trazodone (DRUG), Acute episodic hypoxia (PROCEDURE), Supplemental oxygen (PROCEDURE), Sham (PROCEDURE).
Who is sponsoring clinical trial NCT02922894?
This trial is sponsored by John D. Dingell VA Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02922894 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.
COMPLETED · Phase 4
-
Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)
COMPLETED · Phase 4
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.